You have no items in your shopping cart.
Targeted
In this section you will find Therapeutics Line of Treatment Targeted market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
| Items 1 to 10 of 12 total |
Page:
|
Show per page |
| View as: List Grid |
Sort by
|
Personalized Medicine 2010 Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
Published by Arrowhead Publishers on May 1st, 2010
€ 0.00
The era of Personalized Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology rapidly expands, a personalized approach to medical care is becoming... Learn More
Therapeutic Monoclonal Antibodies Markets
Published by TriMark Publications LLC on Jun 1st, 2009
€ 1,699.00
With a unique ability to specifically target diseased cells while leaving healthy cells unaffected, monoclonal antibodies can serve to diagnose and treat a wide range of medical conditions. Learn More
Therapeutic Monoclonal Antibodies Report 2008-2023
Published by Visiongain on Jul 25th, 2008
€ 1,924.00
This report examines the market for monoclonal antibodies critically, through comprehensive primary and secondary research. In addition to consultation with experts in industry - including full interview transcripts - this research involved a detailed study of relevant documents, industrial reports and current developments. Learn More
Cancer Antibodies: Competitive Positioning for Success
Published by BioSeeker Group on Jun 3rd, 2008
€ 1,950.00
This report is written for you to identify your competition and understand which targeting strategies are at work within antibody drug development. It allows you to pin-point which competitors drugs’ clinical out-come may have bearing on your own drug development and who are developing sequels to blockbuster drugs. This report also helps you to locate white-spots in the competitive landscape, giving you little or no competition. Conversely it may reveal unexpected competition for you. Learn More
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
Published by BioSeeker Group on Apr 1st, 2008
€ 2,300.00
The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. Targeted biologics utilizing monoclonal antibody-based technologies have rapidly developed into one of the major market segments of the pharmaceutical industry. Learn More
The Complete Guide to Targeted Therapies in Oncology: A World Review
Published by BioSeeker Group on Dec 19th, 2006
€ 4,950.00
In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology. Learn More
Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology
Published by BioSeeker Group on Oct 9th, 2006
€ 1,950.00
Assess opportunities and risks for the continued development of anti-angiogenic and vascular targeting agents in five major cancer indications. Learn More
Lymphoma - A Therapeutic & Competitive Insight
Published by BioSeeker Group on May 29th, 2006
€ 1,950.00
Gain insight into the current challenges and commercial opportunities associated with lymphoma therapy Learn More
Complete Target Atlas in Oncology Drug Development: From Tumor to Targeted Therapy
Published by BioSeeker Group (Multi-report (See individual release dates))
€ 7,950.00
This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More
Triple Target Atlas in Oncology Drug Development
Published by BioSeeker Group (Multi-report (See individual release dates))
€ 3,450.00
This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More
| Items 1 to 10 of 12 total |
Page:
|
Show per page |
| View as: List Grid |
Sort by
|